[go: up one dir, main page]

WO1996019099A3 - Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee - Google Patents

Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee Download PDF

Info

Publication number
WO1996019099A3
WO1996019099A3 PCT/IB1996/000444 IB9600444W WO9619099A3 WO 1996019099 A3 WO1996019099 A3 WO 1996019099A3 IB 9600444 W IB9600444 W IB 9600444W WO 9619099 A3 WO9619099 A3 WO 9619099A3
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
analogues
derivatives
elastin synthesis
promoting skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB1996/000444
Other languages
English (en)
Other versions
WO1996019099A2 (fr
Inventor
Marc Dumas
Frederic Bonte
Alain Meybeck
Catherine Chaudagne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LVMH Recherche GIE
Original Assignee
LVMH Recherche GIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LVMH Recherche GIE filed Critical LVMH Recherche GIE
Priority to AU54077/96A priority Critical patent/AU5407796A/en
Priority to US08/817,978 priority patent/US5801192A/en
Priority to GB9708362A priority patent/GB2308811B/en
Priority to JP51964796A priority patent/JP4313846B2/ja
Priority to DE19680859T priority patent/DE19680859T1/de
Publication of WO1996019099A2 publication Critical patent/WO1996019099A2/fr
Publication of WO1996019099A3 publication Critical patent/WO1996019099A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne l'utilisation de l'acide ascorbique notamment de l'acide L-ascorbique ou vitamine C, ou de son isomère l'acide érythorbique, ou de leurs sels ou esters, pour stimuler la synthèse d'élastine dans le derme en vue d'améliorer en particulier l'élasticité cutanée. L'invention permet de fabriquer des compositions cosmétiques ou pharmaceutiques, notamment dermatologiques, pour améliorer l'élasticité cutanée, par exemple dans le cadre de produit améliorant la tonicité cutanée ou raffermissant cutané. L'invention permet également d'augmenter la teneur en élastine de dermes artificiels.
PCT/IB1996/000444 1995-08-25 1996-05-10 Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee Ceased WO1996019099A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU54077/96A AU5407796A (en) 1995-08-25 1996-05-10 Use of vitamin c or derivatives or analogues thereof for promoting skin elastin synthesis
US08/817,978 US5801192A (en) 1995-08-25 1996-05-10 Use of vitamin C or derivatives or analogues thereof promoting skin elastin synthesis
GB9708362A GB2308811B (en) 1995-08-25 1996-05-10 Use of vitamin C or derivatives or analogues thereof for promoting skin elastin synthesis
JP51964796A JP4313846B2 (ja) 1995-08-25 1996-05-10 ビタミンｃ若しくはその誘導体又はそれらの類似体の，皮膚エラスチン合成促進のための使用
DE19680859T DE19680859T1 (de) 1995-08-25 1996-05-10 Verwendung von Vitamin C oder seiner Derivate oder Analoga zur Stimulierung der Synthese von Haut-Elastin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR95/10093 1995-08-25
FR9510093A FR2737971B1 (fr) 1995-08-25 1995-08-25 Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee

Publications (2)

Publication Number Publication Date
WO1996019099A2 WO1996019099A2 (fr) 1996-06-27
WO1996019099A3 true WO1996019099A3 (fr) 1997-04-10

Family

ID=9482092

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB1996/000444 Ceased WO1996019099A2 (fr) 1995-08-25 1996-05-10 Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee

Country Status (13)

Country Link
US (1) US5801192A (fr)
JP (1) JP4313846B2 (fr)
AU (1) AU5407796A (fr)
BE (1) BE1009858A5 (fr)
CA (1) CA2202629A1 (fr)
CH (1) CH690489A5 (fr)
DE (1) DE19680859T1 (fr)
ES (1) ES2129013B1 (fr)
FR (1) FR2737971B1 (fr)
GB (1) GB2308811B (fr)
IT (1) IT1284758B1 (fr)
NL (1) NL1003883C2 (fr)
WO (1) WO1996019099A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2768927B1 (fr) * 1997-10-01 2000-01-21 Lvmh Rech Utilisation de l'acide ellagique, de ses sels, de ses complexes metalliques, de ses derives mono- ou poly-ethers, mono- ou poly-acyles dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie
US6809075B1 (en) 2000-05-30 2004-10-26 Connective Tissue Imagineering Llc Elastin peptide analogs and uses of same incombination with skin enhancing agents
US6962904B1 (en) 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
US6777389B1 (en) 1998-11-19 2004-08-17 Connective Tissue Imagineering Llc Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides
FR2791259B1 (fr) * 1999-03-24 2001-08-17 Roche Posay Lab Pharma Utilisation de la vitamine c ou analogues pour augmenter le taux de differenciation et/ou de proliferation des cellules de la peau
FR2791261A1 (fr) * 1999-03-24 2000-09-29 Roche Posay Lab Pharma Utilisation de la vitamine c ou analogue pour promouvoir la transformation de procollagenes inactifs en collagenes actifs
US6184247B1 (en) * 1999-05-21 2001-02-06 Amway Corporation Method of increasing cell renewal rate
FR2795956B1 (fr) * 1999-07-06 2006-07-14 Inst Evaluation Dermatophysiqu Composition cosmetique pour ameliorer l'elasticite de la peau et lutter contre son vieillissement
WO2001043711A1 (fr) * 1999-12-14 2001-06-21 Unilever Plc Composition cosmetique de creme revitalisante a base d'extrait de riz a levure rouge
FR2807322B1 (fr) 2000-04-10 2004-02-20 Oreal Composition, notamment cosmetique, comprenant de l'acide ascorbique en association avec un derive d'acide ascorbique
FR2807320B1 (fr) * 2000-04-10 2002-05-24 Oreal Utilisation de derives d'acide ascorbique pour augmenter la synthese des creramides epidermiques
US6794362B1 (en) 2000-05-30 2004-09-21 Connective Tissue Imagineering Llc Asparagine containing elastin peptide analogs
US6468552B1 (en) * 2000-06-02 2002-10-22 Neutrogena Corporation Stabilized compositions containing oxygen-labile active agents
US6576248B1 (en) 2000-09-11 2003-06-10 Avon Products, Inc. Pigmented vitamin C composition
WO2003017942A2 (fr) * 2001-08-24 2003-03-06 Rath Matthias M D Derives uniques d'acide ascorbique comprenant des acides amines essentiels, des acides amines non essentiels et des acides amines non presents les proteines, procede de preparation et d'utilisation de ces derives dans la recherche, la medecine, la physiologie, la pharmacologie, la nutrition, les produits pharmaceutiques, ai
HRP20040207A2 (en) 2001-08-24 2005-02-28 Rath Matthias Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
FR2832630B1 (fr) * 2001-11-28 2005-01-14 Oreal Composition cosmetique et/ou dermatologique contenant au moins un actif hydrophile sensible a l'oxydation stabilise par au moins un copolymere de n-vinylimidazole
KR100505105B1 (ko) * 2001-12-20 2005-07-29 샘즈바이오 주식회사 삼중 코팅구조의 비타민 에이씨(레티닐 팔미테이트와순수비타민 씨) 및 그를 함유하는 화장료 조성물
ES2254885T3 (es) * 2002-06-20 2006-06-16 L'oreal Utilizacion cosmetica y/o dermatologica de una composicion que contiene al menos un agente hidrofilo sensible a la oxidacion por al menos un copolimero de anhidrido maleico.
FR2846005B1 (fr) * 2002-10-16 2006-06-23 Maco Pharma Sa Composition pour milieu biologique comprenant de l'erythorbate de sodium
WO2004056383A1 (fr) * 2002-12-20 2004-07-08 Council Of Scientific And Industrial Research Composition vegetale pour les coupures, les brulures et les plaies
US7025966B2 (en) 2003-12-05 2006-04-11 Mary Kay Inc. Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
JP2005247826A (ja) * 2004-02-04 2005-09-15 Kose Corp デコリン産生促進剤及びそれを含有する皮膚外用剤
KR100868905B1 (ko) * 2004-03-26 2008-11-14 (주)아모레퍼시픽 진세노사이드 ｆ1과 ｅｇｃｇ을 함유한 자외선 조사로유도되는 피부손상 방지용 조성물
JP2009500394A (ja) * 2005-07-08 2009-01-08 ザ プロクター アンド ギャンブル カンパニー パーソナルケア組成物及び哺乳類の皮膚と毛髪を美化する方法
EP1940816A2 (fr) * 2005-09-30 2008-07-09 OMP, Inc. Compositions stables d'acide ascorbique
US20070178058A1 (en) * 2006-02-02 2007-08-02 Ramirez Jose E Methods of using stable ascorbic acid compositions
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
DE102006035040A1 (de) * 2006-07-28 2008-01-31 Beiersdorf Ag Wirkstoffkombinationen aus Ascorbylverbindung und hydriertem Lecithin
FR2911779B1 (fr) 2007-01-30 2009-04-24 Lvmh Rech Composition contenant un extrait d'ambre
IT1397735B1 (it) * 2010-01-18 2013-01-24 Binda Composizione cosmetica ad attivita' idratante ed antiossidante.
JP5679684B2 (ja) * 2010-03-17 2015-03-04 グンゼ株式会社 Ｄａｎｃｅタンパク質含有組織再生用基材
EP2484387A1 (fr) * 2011-02-03 2012-08-08 Q-Med AB Composition d'acide hyaluronique
US20130089641A1 (en) * 2011-10-11 2013-04-11 Sunway Biotech Co., Ltd. Soymilk with Additive of Vitamin C, Vitamin C salt or Vitamin C Stereoisomer
FR2994846B1 (fr) 2012-08-29 2014-12-26 Vivacy Lab Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
DK3072535T5 (en) * 2015-03-26 2017-06-06 Univ Bordeaux METHOD OF RECONSTRUCTION OF SKIN
ITUB20152183A1 (it) * 2015-07-15 2017-01-15 Germano Laghi Miscela di principi attivi cosmetici per la preparazione di un gel cosmetico e metodo per la preparazione di detto gel
KR102354282B1 (ko) * 2017-05-17 2022-01-21 주식회사 엘지생활건강 에리소르빈산을 포함하는 화장료 조성물
JP2019069912A (ja) * 2017-10-06 2019-05-09 株式会社シャネル化粧品技術開発研究所 非水系皮膚外用組成物およびその製造方法
WO2020081868A1 (fr) * 2018-10-18 2020-04-23 Baek Clinical Inc. Formulations topiques de vitamine c à dosage élevé
CA3177400A1 (fr) 2020-04-16 2021-10-21 Baek Clinical Inc. Stabilisation de formulations d'application de vitamine c

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6379809A (ja) * 1986-09-22 1988-04-09 Shiseido Co Ltd 皮膚外用剤
EP0282746A1 (fr) * 1987-02-19 1988-09-21 Takeda Chemical Industries, Ltd. Procédé de préparation de tissu cultivé de manière artificielle
FR2612775A1 (fr) * 1987-03-25 1988-09-30 Thorel Jean Compositions pour la prevention et le traitement de la degenerescence cutanee
US4938969A (en) * 1988-11-14 1990-07-03 Milor Scientific, Ltd. Method for the treatment of aging or photo-damaged skin
US4983382A (en) * 1987-01-27 1991-01-08 Avon Products, Inc. Cosmetic preparation incorporating stabilized ascorbic acid
FR2666226A1 (fr) * 1990-08-30 1992-03-06 Jean Noel Thorel Composition protectrice de la peau.
WO1995025524A1 (fr) * 1994-03-18 1995-09-28 Lvmh Recherche UTILISATION DU GINSENOSIDE Ro OU D'UN EXTRAIT VEGETAL EN CONTENANT POUR STIMULER LA SYNTHESE DU COLLAGENE
DE4419783A1 (de) * 1994-06-06 1995-12-07 Asta Medica Ag Haarkur-Pflege-Shampoo

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5262635A (en) * 1975-11-20 1977-05-24 Matsushita Electric Industrial Co Ltd Method of producing zinc electrode
EP0537092A1 (fr) * 1991-10-08 1993-04-14 Patrinove Societe Civile Vecteurs vésiculaires infracellulaires et leurs applications dans les compositions cosmétiques, médicamenteuses et les milieux de culture
FR2735982B1 (fr) * 1995-06-27 1997-09-19 Lvmh Rech Composition cosmetique ou pharmaceutique contenant un extrait de plantes du genre filicium

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6379809A (ja) * 1986-09-22 1988-04-09 Shiseido Co Ltd 皮膚外用剤
US4983382A (en) * 1987-01-27 1991-01-08 Avon Products, Inc. Cosmetic preparation incorporating stabilized ascorbic acid
EP0282746A1 (fr) * 1987-02-19 1988-09-21 Takeda Chemical Industries, Ltd. Procédé de préparation de tissu cultivé de manière artificielle
FR2612775A1 (fr) * 1987-03-25 1988-09-30 Thorel Jean Compositions pour la prevention et le traitement de la degenerescence cutanee
US4938969A (en) * 1988-11-14 1990-07-03 Milor Scientific, Ltd. Method for the treatment of aging or photo-damaged skin
FR2666226A1 (fr) * 1990-08-30 1992-03-06 Jean Noel Thorel Composition protectrice de la peau.
WO1995025524A1 (fr) * 1994-03-18 1995-09-28 Lvmh Recherche UTILISATION DU GINSENOSIDE Ro OU D'UN EXTRAIT VEGETAL EN CONTENANT POUR STIMULER LA SYNTHESE DU COLLAGENE
DE4419783A1 (de) * 1994-06-06 1995-12-07 Asta Medica Ag Haarkur-Pflege-Shampoo

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 12, no. 306 (C - 522)<3153> *
STN, Serveur de Bases de Données, Fichier *

Also Published As

Publication number Publication date
BE1009858A5 (fr) 1997-10-07
GB2308811A (en) 1997-07-09
ITTO960710A1 (it) 1998-02-20
JP4313846B2 (ja) 2009-08-12
NL1003883A1 (nl) 1997-02-27
GB2308811B (en) 2000-04-05
FR2737971B1 (fr) 1997-11-14
FR2737971A1 (fr) 1997-02-28
DE19680859T1 (de) 1997-10-02
ES2129013B1 (es) 2000-04-01
US5801192A (en) 1998-09-01
GB9708362D0 (en) 1997-06-18
AU5407796A (en) 1996-07-10
IT1284758B1 (it) 1998-05-21
GB2308811A8 (en) 1999-05-21
CA2202629A1 (fr) 1996-06-27
ES2129013A1 (es) 1999-05-16
WO1996019099A2 (fr) 1996-06-27
JPH10509735A (ja) 1998-09-22
CH690489A5 (fr) 2000-09-29
NL1003883C2 (nl) 1997-02-27

Similar Documents

Publication Publication Date Title
WO1996019099A3 (fr) Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l&#39;elastine cutanee
US5962482A (en) Method of reducing cellulite in mamalian skin
IL99291A (en) Cosmetic preparations
EP0852949A3 (fr) Utilisation des alpha-aminoacides pour favoriser la dégradation des desmosomes ou la desquamation du stratum corneum
DE69902131D1 (de) Kosmetische und/oder dermatologische Zusammensetzung enthaltend Salicylsäure oder ihre Derivate und ihre Verwendung
EP2022484A3 (fr) Composition cosmétique cutanée
EP0255364A3 (fr) Composition cosmétique anhydre
CA2119636A1 (fr) Gel cosmetique aqueux a ph faible renfermant des derives de polyacrylamide non ioniques
CA2288760A1 (fr) Ascorbyl-phoshoryl-cholesterol
CA2044269A1 (fr) Compositions pharmaceutiques et cosmetiques depigmentantes a base d&#39;acide cafeique
AU3459789A (en) Aqueous compositions of pyroglutamic acid esters for topical application to human skin and hair
WO1997001343A3 (fr) Utilisation comme substances therapeutiquement actives ou produits cosmetiques des sophorolipides, en particulier pour le traitement de la peau
MXPA03005510A (es) Composiciones y metodos para tratar hiperpigmentacion.
WO2000057836A3 (fr) Compositions cosmetiques ou dermatologiques contenant au moins une substance destinee a augmenter la fonctionnalite et/ou l&#39;expression des recepteurs membranaires cd44 des cellules de la peau
TW200503767A (en) Improved cosmetic composition
WO1996005797A3 (fr) Agent a application externe aux proprietes nutritives et protectrices
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
ATE227973T1 (de) Kosmetische, dermatologische und pharmazeutische anwendung eines terminalia catappa pflanzenextrakts
DE69717495D1 (de) Verwendung eines terminalia catappa extraktes
JP2003300818A (ja) 化粧品
KR970032819A (ko) 미백화장료 조성물
DE3862440D1 (de) Pharmazeutische oder kosmetische zusammensetzung mit gehalt an hydrochinon und kojisaeure in liposomen.
CA2075926A1 (fr) Esters d&#39;acides amines et d&#39;hydroquinone, methodes d&#39;obtention et compositions phramaceutiques ou cosmetiques qui en contiennent
JP2014210762A (ja) 皮脂分泌抑制剤
JP2004519413A (ja) 局所微量栄養素送達システムおよびその用途

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2202629

Country of ref document: CA

Ref document number: 2202629

Country of ref document: CA

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 9750014

Country of ref document: ES

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 08817978

Country of ref document: US

Ref document number: P009750014

Country of ref document: ES

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i
RET De translation (de og part 6b)

Ref document number: 19680859

Country of ref document: DE

Date of ref document: 19971002

WWE Wipo information: entry into national phase

Ref document number: 19680859

Country of ref document: DE

WWP Wipo information: published in national office

Ref document number: 9750014

Country of ref document: ES

Kind code of ref document: A

122 Ep: pct application non-entry in european phase
WWG Wipo information: grant in national office

Ref document number: 9750014

Country of ref document: ES

Kind code of ref document: A

WWX Former pct application expired in national office

Ref document number: 9750014

Country of ref document: ES

Kind code of ref document: A